SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ATIS is on the move!
ATIS 0.1000-47.4%Apr 14 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Marshall Teitelbaum who wrote (1276)1/8/1998 5:12:00 PM
From: Paul Shield  Read Replies (1) of 2205
 
Marshall, I just saw your second post so I'll respond separately. I hope for your sake that your judgment about ATIS is better than about RAIN.As far as your objections -- My understanding is that ORG will file for cryopreserved once approved. The procedure is much easier to modify approval -- it was the easiest way to go. However, doctors routinely administer vaccines on an as needed basis and 5 days is plenty of time. I don't have the time to go into details but it is easily cost effective. I raise a question about ATIS product -- if it needs 8 applications, how is it cost effective? The cost per sheet of tissue will be less but the protocol was for more applications -- Right? I have my concerns about ATIS product -- The nylon mesh concerns me as it should everyone else - All these artificial products have caused problems in the past -- witness silicon breast implants and the clogging off of artifical blood vessels that teflon was supposed to keep from happening. Moreover, the mesh gives a functional monolayer that is not physiologic. It could cause problems or make for a poorer "take" than ORG's product. In any case, the FDA and then the market place will have the final say.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News